integrated incremental immunoreactive insulin and connecting peptide responses to an oral glucose load of 50 g and an `` '' isoglycaemic '' '' intravenous glucose infusion , respectively , were measured in 14 type 2 ( non-insulin-dependent ) diabetic patients and 8 age- and weight-matched metabolically healthy control subjects .
C0021641
insulin
C0011860
( non-insulin-depende